ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients-Reference-Cited by-同舟云学术

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Published:2020-03 Issue: Volume:127 Page:52-66
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Pearson Andrew D.J.^ORCID,Rossig Claudia^ORCID,Lesa Giovanni,Diede Scott J.,Weiner Susan,Anderson John,Gray Juliet,Geoerger Birgit,Minard-Colin Veronique^ORCID,Marshall Lynley V.,Smith Malcolm,Sondel Paul,Bajars Marcis,Baldazzi Claudia,Barry Elly,Blackman Sam,Blanc Patricia,Capdeville Renaud^ORCID,Caron Hubert,Cole Peter D.,Jiménez Jorge Camarero,Demolis Pierre,Donoghue Martha,Elgadi Mabrouck,Gajewski Thomas^ORCID,Galluzzo Sara,Ilaria Robert,Jenkner Alessandro,Karres Dominik,Kieran Mark^ORCID,Ligas Franca,Lowy Israel,Meyers Michael,Oprea Corina,Peddareddigari Vijay G.R.,Sterba Jaroslav,Stockman Paul K.^ORCID,Suenaert Peter^ORCID,Tabori Uri,van Tilburg Cornelis,Yancey Todd,Weigel Brenda,Norga Koenraad,Reaman Gregory,Vassal Gilles

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference90 articles.

1. New drugs for children and adolescents with cancer: the need for novel development pathways;Vassal;Lancet Oncol,2013

2. Implementation of mechanism of action biology-driven early drug development for children with cancer;Pearson;Eur J Cancer,2016

3. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2017/06/WC500228940.pdf (Accessed 20 January 2020).

4. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children;Pearson;Eur J Cancer,2019

5. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4;Probst;Nat Immunol,2005

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GD2 targeting CAR T cells for neuroblastoma;EJC Paediatric Oncology;2024-12

2. Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer;European Journal of Cancer;2024-08

3. Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer;Journal of Clinical Oncology;2024-07-20

4. The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma;Cell Death & Disease;2024-06-18

5. Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed;Journal of Clinical Oncology;2024-01-20